APA (7th ed.) Citation

Katamesh, A. A., Abdel-Bar, H. M., Break, M. K. B., Hassoun, S. M., Subaiea, G. M., Radwan, A., & Abo El-Enin, H. A. (2025). Tailored Intranasal Albumin Caged Selegiline-α Synuclein siRNA Liposome with Improved Efficiency in Parkinson's Model. Pharmaceutics, 17(2), 243. https://doi.org/10.3390/pharmaceutics17020243

Chicago Style (17th ed.) Citation

Katamesh, Ahmed A., Hend Mohamed Abdel-Bar, Mohammed Khaled Bin Break, Shimaa M. Hassoun, Gehad Mohammed Subaiea, Amr Radwan, and Hadel A. Abo El-Enin. "Tailored Intranasal Albumin Caged Selegiline-α Synuclein SiRNA Liposome with Improved Efficiency in Parkinson's Model." Pharmaceutics 17, no. 2 (2025): 243. https://doi.org/10.3390/pharmaceutics17020243.

MLA (9th ed.) Citation

Katamesh, Ahmed A., et al. "Tailored Intranasal Albumin Caged Selegiline-α Synuclein SiRNA Liposome with Improved Efficiency in Parkinson's Model." Pharmaceutics, vol. 17, no. 2, 2025, p. 243, https://doi.org/10.3390/pharmaceutics17020243.